Fig. 3From: Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analysesDisease evolution in the brain under crizotinib treatment. BBM, baseline brain metastases; PD, progressive disease; RT, radiotherapy; oligo-PD, oligo-progressive disease; multiple-PD, multiple-progressive diseaseBack to article page